SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001328143-21-000029
Filing Date
2021-02-25
Accepted
2021-02-25 16:00:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 admsform424b5final022521.htm 424B5 449988
2 adamaslogo22a.jpg GRAPHIC 148586
3 adamaslogoa011a.jpg GRAPHIC 11911
  Complete submission text file 0001328143-21-000029.txt   666781
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234570 | Film No.: 21680130
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences